Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in LKFT — Lakefront Biotherapeutics NV

CIK 1387508 NEW YORK, NY

Position in LKFT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$578,763
-$387 QoQ
Shares Held
19,305
0.0% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#29
of 78 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LKFT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $41,687,806 across 71 Biotechnology names. LKFT ranks #12 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LKFT

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $578,763 19,305
2026-03-31 $579,150 19,305
2025-12-31 $631,273 19,305
2025-09-30 $669,487 19,327
2025-06-30 $540,346 19,305
2025-03-31 $484,941 19,305
2024-12-31 $526,212 19,135
2024-09-30 $550,896 19,135
2024-06-30 $213,900 8,632
2023-12-31 $271,704 6,684
2023-09-30 $230,794 6,680
2023-06-30 $269,779 6,635
2023-03-31 $256,376 6,635
2022-12-31 $471,537 10,625
2022-09-30 $624,761 14,652
2022-06-30 $816,912 14,640
2022-03-31 $1,845,715 29,760
2021-12-31 $1,240,700 22,505